GABELLI FUNDS LLC - NABRIVA THERAPEUTICS PLC ownership

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$9,000
-25.0%
17,5590.0%0.00%
Q2 2020$12,000
+20.0%
17,5590.0%0.00%
Q1 2020$10,000
-56.5%
17,5590.0%0.00%
Q4 2019$23,000
-34.3%
17,5590.0%0.00%
Q3 2019$35,000
-18.6%
17,5590.0%0.00%
Q2 2019$43,0000.0%17,5590.0%0.00%
Q1 2019$43,000
+65.4%
17,5590.0%0.00%
Q4 2018$26,000
-44.7%
17,5590.0%0.00%
Q3 2018$47,00017,5590.00%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 4,256,526$11,493,0002.10%
Vivo Capital, LLC 6,619,190$17,872,0001.80%
Novo Holdings A/S 4,703,720$12,700,0001.01%
Rock Springs Capital Management LP 1,800,000$4,860,0000.18%
Orbimed Advisors 4,644,600$12,540,0000.15%
Clear Harbor Asset Management, LLC 212,500$443,0000.09%
Granahan Investment Management 247,276$668,0000.04%
WEDBUSH SECURITIES INC 92,050$249,0000.03%
Laurion Capital Management LP 419,670$1,133,0000.01%
SECTORAL ASSET MANAGEMENT INC 38,255$103,0000.01%
View complete list of NABRIVA THERAPEUTICS PLC shareholders